Acupuncture/Moxibustion for Peripheral Neuropathy in HIV
Peripheral Neuropathies, HIV Infections
About this trial
This is an interventional treatment trial for Peripheral Neuropathies focused on measuring Acupuncture, HIV, AIDS, Symptom management, Non-invasive, Complementary Therapies, Treatment Experienced
Eligibility Criteria
Inclusion Criteria: Men and women who are HIV positive or Centers for Disease Control (CDC)-defined AIDS diagnosed subjects who are 18 years of age or older, and have a history of distal symmetrical peripheral neuropathy of the lower extremities (legs and feet) for two months or greater. Patients experiencing moderate pain severity. Verification from primary provider of subject's: HIV status, diagnosis of DSP, and agreement that patient is clinically suitable for the study. Individuals able to successfully complete a mini-mental status exam. Individuals who understand and agree to complete daily symptom diaries for the duration of the study. Individuals taking antiretroviral combinations must have completed an initial 8 weeks of a stable regime (same drug[s], dose, and frequency) prior to entry into the study. Individuals taking chronic pain medications must be on a stable regime (same drug, dose, and frequency) for at least twenty-one (21) days prior to entry into the study. Individuals on all other medications which may have neuropathy listed as a side effect must be on a stable regime (same drug[s], dose, and frequency) for at least 21 days prior to entry in the study. Exclusion Criteria: Individuals with an acute medical condition, i.e. pneumocystis carinii pneumonia, tuberculosis, and/or other opportunistic infections or conditions that would require medical attention. Individuals with diagnosis of diabetes mellitus, B-12 deficiency Topically applied medications to the lower extremities. Individuals with alcohol and/or substance dependence. Individuals with bleeding tendency Currently receiving treatment with corticosteroids Use of isoniazid (INH), dapsone, or metronidazole within 8 weeks prior to enrollment. Severe heart disease, uncontrolled high blood pressure, lung disease, or renal failure. Pregnant women Individuals receiving acupuncture currently and less than 6 months prior to enrollment. Individuals with a history of receiving moxibustion. Individuals currently receiving other types of complementary therapies such as herbs, massage, reiki, etc. Individuals with plans for travel, lifestyle change, or other activity that would preclude attending all of the planned study sessions and/or recording daily diary information.
Sites / Locations
- Columbia University School of Nursing, Acupuncture Laboratory
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Acupuncture/Moxibustion
Sham acupuncture/Placebo moxibustion
Acupuncture/Moxibustion for Peripheral Neuropathy in HIV
Sham acupuncture/Placebo moxibustion for Peripheral Neuropathy in HIV